Ciro Franzese, Director of Radiation Oncology Unit at Humanitas San Pio X, Associate Professor at Humanitas University, shared on LinkedIn:
“That’s a wrap on EMUC26 for me too!
Intense and inspiring days, filled with scientific updates, provoking insights, and valuable discussions on the future of genitourinary oncology.
Once again, even in Brussels, I felt a little bit at home, thanks to a wonderful international group of friends and colleagues with whom it’s always a pleasure to share ideas, experiences, and a few lighter moments along the way.”
\
The European Multidisciplinary Congress on Urological Cancers (EMUC26) is Europe’s premier scientific and clinical forum dedicated to the advancement of genitourinary (GU) oncology.
As the flagship multidisciplinary event in its field, the congress serves as the definitive global platform for establishing the standard of care, sharing clinical trial data, and driving collaborative research across all urological malignancies, including prostate, kidney, bladder, and testicular cancers.
You can also read:
Guillaume Grisay: Early Genetic Testing Takes Center Stage in Metastatic Prostate Cancer at EMUC26
